Back to Journals » Journal of Inflammation Research » Volume 3

Current and emerging strategies for the treatment of acute pericarditis: a systematic review

Authors Sheth, Wang DD, Kasapis C

Published 25 November 2010 Volume 2010:3 Pages 135—142


Review by Single anonymous peer review

Peer reviewer comments 3

Samar Sheth1, Dee Dee Wang3, Christos Kasapis2
1Department of Internal Medicine, 2Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA; 3Henry Ford Hospital, Division of Cardiovascular Medicine, Detroit, MI, USA

Abstract: Pericarditis is a common disorder that has multiple causes and presents in various primary-care and secondary-care settings. It is diagnosed in 0.1% of all hospital admissions and in 5% of emergency room visits for chest pain. Despite the advance of new diagnostic techniques, pericarditis is most commonly idiopathic, and radiation therapy, cardiac surgery, and percutaneous procedures have become important causes. Pericarditis is frequently benign and self-limiting. Nonsteroidal anti-inflammatory agents remain the first-line treatment for uncomplicated cases. Integrated use of new imaging methods facilitates accurate detection and management of complications such as pericardial effusion or constriction. In this article, we perform a systematic review on the etiology, clinical presentation, diagnostic evaluation, and management of acute pericarditis. We summarize current evidence on contemporary and emerging treatment strategies.

Keywords: pericarditis, pericardial disease, treatment strategies

Creative Commons License © 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.